CONTACT: Nate Banner, Neogen Corporation, 517/372-9200 LANSING, Mich., Feb. 1, 2018 — Neogen Corporation (NASDAQ: NEOG) today announced that it has released BetaStar® Advanced — the easiest method to test for antibiotics in milk. BetaStar Advanced has been reviewed by the FDA, approved for use by the National Conference on Interstate Milk Shipments (NCIMS), and validated by the AOAC... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today that a federal jury in San Francisco has ruled in its favor in a patent infringement suit filed against Ariosa Diagnostics, Inc., now owned by Roche. The jury found that both Ariosa’s previous and current version of the Harmony non-invasive prenatal test (NIPT) infringe US Patent 8,318,430... Read more
MENLO PARK, California and SHENZHEN, China, Jan. 25, 2018 (GLOBE NEWSWIRE) — BGI, one of the world’s largest genomics organizations, and Pacific Biosciences of California, Inc. (Nasdaq: PACB), the leader in long-read sequencing, today announced an agreement by BGI Genomics to purchase an additional 10 Sequel® Systems. This will significantly expand the capacity for Single Molecule, Real-Time... Read more
January 19, 2018 For LabSolutions LCMS Mycotoxins are highly toxic chemical byproducts from fungi commonly found in crops, and residual content in foods are regulated the world over. This method package provides simultaneous multi-component analysis conditions for mycotoxins subject to the regulations in Japan, the USA, the EU, and China. Analytical Methods for 27 Mycotoxins... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today the launch of the iSeq™ 100 Sequencing System. The new, next-generation sequencing (NGS) system delivers exceptional data accuracy, at a low capital cost, making Illumina technology available to virtually any lab. The combination of the company’s proven sequencing by synthesis (SBS) chemistry, along with the complementary metal-oxide-semiconductor... Read more
Thermo Fisher Scientific and Illumina Sign Agreement to Provide Research Market Broader Access to Ion AmpliSeq Technology Industry-leading amplicon solution facilitates targeted next-generation sequencing in multiple application areas Thermo Fisher Scientific and Illumina, Inc.(NASDAQ: ILMN) today announced they have signed a commercial agreement that enables Illumina to sell Ion AmpliSeq technology to researchers who conduct... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) and KingMed Diagnostics (SSE: 603882.SS) today announced an agreement to jointly develop novel oncology and hereditary disease testing applications utilizing Illumina’s next-generation sequencing (NGS) technology. The collaboration is a significant step toward China Food and Drug Administration (CFDA) review and approval, and serves as a starting point to deliver... Read more
CONTACT: Steve Quinlan, Vice President & CFO, 517/372-9200 LANSING, Mich., Jan. 2, 2018 — Neogen Corporation (NASDAQ: NEOG) today announced that all shares of its common stock will begin trading today on a “post-split” basis to reflect the company’s previously announced 4-for-3 stock split. Accordingly, the price of the common stock will automatically be adjusted downward by... Read more
Germantown, Maryland, and Hilden, Germany, December 22, 2017 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announces that, mainly as a consequence of the new U.S. tax legislation, it will take an after-tax charge on net income of approximately $110-120 million (or about $0.47-$0.52 per share) in the fourth quarter of 2017, and an... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be presenting at the following investor conference and invited investors to participate via webcast. J.P. Morgan Healthcare Conference Presentation, San Francisco, CaliforniaMonday, January 8, 2018 at 3:30 pm Pacific Time J.P. Morgan Healthcare Conference Question & Answer Session, San Francisco, CaliforniaMonday, January 8, 2018 at... Read more